They have a great product treating cancer with immunotherapy, peer reviewed journal

look into Adamis Pharma, no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!

2023 is going to be very positive for patients of our products and shareholders alike

Their product works (see the mad Pole Piotr’s graphs 😵‍💫) Multi year holds, the bodadem.

We have great data out of a superior product,

They have good products and a solid future.

$BXRX Even if they don't sell Anjeso, the product is unique in a market with great potential.

$EMED QB ticker announced new product , .01-.03 nice % incoming i believe

$BXRX THE COMPANY HAS AN EXCELLENT PRODUCT MILOXICAM IV FOR PAIN RELIEF.

A unique product on the market that will soon be marketed internationally as well.

I think that's a good number considering all the work that goes into launching a product.

Super excited for tomorrow's ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!

It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.

Imagine how much Ubli could be worth to BP now with Briumvi’s best in class product profile.

$TGTX This gonna be amazing guys after they sell their product Lets say 50.000 usd for the dose and they sell 500 a month Make the math and tell me how revenue they will get every quarter

This is not some get rich scheme, this is a solid biotech company with an approved product that will bring in billions in revenue.